Alembic Pharmaceuticals board to consider unaudited financial results

13 Oct 2015 Evaluate

Alembic Pharmaceuticals has informed that a Meeting of the Board of Directors of the Company will be held on October 27, 2015, to consider and approve the Unaudited Financial Results of the Company for the quarter ended on September 30, 2015 (Q2). Further, the trading window shall remain closed from October 24, 2015 to October 29, 2015 for the above purpose.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1055.00 4.85 (0.46%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.